Drugs & Targets HRA Pharma & Celnova Pharma partner to launch medicines in South America for adrenocortical carcinoma HRA Pharma Rare Diseases, a business of Perrigo Company, signed a partnership with Celnova Pharma, to ensure that the products developed by HRA Pharma Rare Diseases can be successfully registered and launched across Argentina, Chile, and Peru.March 03, 2023Vol.49 No.09